Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT00979953

Public ClinicalTrials.gov record NCT00979953. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of ADL5859 and ADL5747 in Subjects With Moderate to Severe Pain Due to Osteoarthritis of the Knee

Study identification

NCT ID
NCT00979953
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry
Enrollment
408 participants

Conditions and interventions

Interventions

  • ADL5859 Drug
  • ADL5747 Drug
  • Oxycodone CR Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2009
Primary completion
Mar 31, 2010
Completion
May 31, 2010
Last update posted
Aug 13, 2015

2009 – 2010

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
11
Facility City State ZIP Site status
Covance CRU, Inc Daytona Beach Florida 32117
Atlanta Knee and Shoulder Clinic, PC Stockbridge Georgia 30281
University Rheumatoloty Center for Clinical Research Chicago Illinois 60612
Clinical Investigation Specialists, Inc Gurnee Illinois 60031
Cresent Medical Research Salisbury North Carolina 28144
New Hanover Medical Research Wilmington North Carolina 28401
Columbus Clinical Research Columbus Ohio 43213
PSB Research Mount Gilead Ohio 43338
Bone Joint & Spine Surgeons, Inc Toledo Ohio 43623
Radient Research Anderson South Carolina 29621
Quality Research San Antonio Texas 78209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00979953, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2015 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00979953 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →